Clinical Trial Update: Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating therapeutic drug monitoring of risankizumab in psoriasis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Risankizumab (risankizumab)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Psoriasis Vulgaris | Phase 4 | Status: UNKNOWN